News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Evinova and Bristol Myers Squibb Partner to Use AI in Clinical Development
Tuesday, February 10, 2026Evinova has entered into a strategic agreement with Bristol Myers Squibb to support the optimisation of clinical trials using artificial intelligence As part of the collaboration Bristol Myers Squibb will use the Cost Optimizer module within Evinovas...
EU Parliament Advances Critical Medicines Act to Bolster Europe's Medicine Supply Security in 2026
Tuesday, February 10, 2026The EU Parliament has progressed the Critical Medicines Act aimed at enhancing Europes pharmaceutical supply chain resilience starting in
EU Parliament Advances Critical Medicines Act to Bolster Europe's Medicine Supply Security in 2026
Monday, February 09, 2026The European Parliament adopted its position on the Critical Medicines Act on January advancing negotiations to enhance Europes pharmaceutical supply chain resilience and competitiveness
Breckenridge Pharmaceutical Enters Strategic Collaboration with Medichem
Friday, February 06, 2026Breckenridge Pharmaceutical Inc the US subsidiary of Towa International has entered into a strategic collaboration with Medichem Solutions SL a subsidiary of Medichem The agreement covers a range of injectable medicines
Recent EU Life Sciences Regulatory Changes – What You Need to Know
Friday, February 06, 2026The EU has reached political agreement on the Pharma Package and proposed simplifications to medical devices regulations alongside a new Biotech Act to boost competitiveness
Relay Therapeutics’ Zovegalisib Receives Breakthrough Therapy Designation from U.S. FDA for Advanced Breast Cancer
Wednesday, February 04, 2026Relay Therapeutics has received Breakthrough Therapy designation from the US Food and Drug Administration for zovegalisib RLY in combination with fulvestrant The designation covers the treatment of adults with PIKCAmutant
Sanofi Gains European Commission Approval for Sarclisa in Combination with VRd for Newly Diagnosed Multiple Myeloma Patients
Wednesday, February 04, 2026Sanofi has received European Commission approval for Sarclisa combined with bortezomib lenalidomide and dexamethasone for newly diagnosed multiple myeloma patients ineligible for autologous stem cell transplant
Sartorius Achieves Considerable Profitable Growth in 2025 with Group Sales Revenue Rising 7.6% to Around 3.5 Billion Euros
Tuesday, February 03, 2026Sartorius a leading provider of equipment and services to the biopharmaceutical industry announced preliminary fullyear results showing sales growth to approximately billion euros on February
Morgan Lewis Bolsters European Life Sciences Platform with Moderna Regulatory Leader Joining Munich Office
Monday, February 02, 2026Morgan Lewis has strengthened its global life sciences capabilities by appointing Dr Alexander Meier former head of legal regulatory strategy at Moderna as a partner in its Munich office to advise on EU regulatory frameworks
Frontage Laboratories Expands Early-Phase Clinical Capabilities to Support Global Drug Development
Saturday, January 31, 2026Frontage Laboratories has expanded its earlyphase clinical research capabilities in the United States and China to better support global drug development The move strengthens the companys ability to deliver faster and highquality
